The rational application of liquid biopsy based on next‐generation sequencing in advanced non‐small cell lung cancer

The rational application of liquid biopsy based on next‐generation sequencing in advanced non‐small cell lung cancer

Abstract Background Plasma and tissue biopsy have both used for targeting actionable driver gene mutations in lung cancer, whose concordance is imperfect. A reliable method to predict the concordance is urgently needed to ease clinical application. Methods A total of 1012 plasma samples, including 5...

Full description

Bibliographic Details
Main Authors: Chenglong Zhao, Jianghua Li, Yongchang Zhang, Rui Han, Yubo Wang, Li Li, Yimin Zhang, Mengxiao Zhu, Jie Zheng, Haiwei Du, Chen Hu, Chengzhi Zhou, Nong Yang, Shangli Cai, Yong He
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Cancer Medicine
Subjects:
circulating tumor DNA
liquid biopsy
next generation sequencing
non‐small cell lung cancer
serum tumor marker
Online Access:https://doi.org/10.1002/cam4.5410

Internet

https://doi.org/10.1002/cam4.5410

Similar Items